25 XP   0   0   10

Genfit
Buy, Hold or Sell?

Let's analyse Genfit together

PenkeI guess you are interested in Genfit. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genfit. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genfit

I send you an email if I find something interesting about Genfit.

Quick analysis of Genfit (30 sec.)










What can you expect buying and holding a share of Genfit? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.36
Expected worth in 1 year
$-1.27
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-2.63
Return On Investment
-76.4%

For what price can you sell your share?

Current Price per Share
$3.44
Expected price per share
$3.31 - $4.04
How sure are you?
50%

1. Valuation of Genfit (5 min.)




Live pricePrice per Share (EOD)

$3.44

Intrinsic Value Per Share

$-9.42 - $11.23

Total Value Per Share

$-8.06 - $12.60

2. Growth of Genfit (5 min.)




Is Genfit growing?

Current yearPrevious yearGrowGrow %
How rich?$67.9m$100.7m-$32.7m-48.2%

How much money is Genfit making?

Current yearPrevious yearGrowGrow %
Making money-$30.7m-$25.2m-$5.5m-17.9%
Net Profit Margin-101.2%-117.5%--

How much money comes from the company's main activities?

3. Financial Health of Genfit (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#427 / 1009

Most Revenue
#195 / 1009

Most Profit
#803 / 1009

Most Efficient
#567 / 1009

What can you expect buying and holding a share of Genfit? (5 min.)

Welcome investor! Genfit's management wants to use your money to grow the business. In return you get a share of Genfit.

What can you expect buying and holding a share of Genfit?

First you should know what it really means to hold a share of Genfit. And how you can make/lose money.

Speculation

The Price per Share of Genfit is $3.4449. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genfit.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genfit, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.36. Based on the TTM, the Book Value Change Per Share is $-0.66 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genfit.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.62-17.9%-0.62-17.9%-0.51-14.7%-0.68-19.7%-0.77-22.5%
Usd Book Value Change Per Share-0.66-19.1%-0.66-19.1%-0.26-7.6%0.185.3%0.113.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.66-19.1%-0.66-19.1%-0.26-7.6%0.185.3%0.113.1%
Usd Price Per Share3.85-3.85-4.39-7.59-3.79-
Price to Earnings Ratio-6.23--6.23--8.65--5.50--2.75-
Price-to-Total Gains Ratio-5.85--5.85--16.83--1.66--1.66-
Price to Book Ratio2.82-2.82-2.17-0.87-0.44-
Price-to-Total Gains Ratio-5.85--5.85--16.83--1.66--1.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.4449
Number of shares290
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.660.18
Usd Total Gains Per Share-0.660.18
Gains per Quarter (290 shares)-190.7453.12
Gains per Year (290 shares)-762.97212.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-763-7730212202
20-1526-15360425414
30-2289-22990637626
40-3052-30620850838
50-3815-3825010621050
60-4578-4588012751262
70-5341-5351014871474
80-6104-6114017001686
90-6867-6877019121898
100-7630-7640021252110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%3.016.00.015.8%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%8.011.00.042.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.019.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%8.011.00.042.1%

Fundamentals of Genfit

About Genfit

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.

Fundamental data was last updated by Penke on 2024-04-09 14:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Genfit.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genfit earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genfit to the Biotechnology industry mean.
  • A Net Profit Margin of -101.2% means that $-1.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genfit:

  • The MRQ is -101.2%. The company is making a huge loss. -2
  • The TTM is -101.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-101.2%TTM-101.2%0.0%
TTM-101.2%YOY-117.5%+16.3%
TTM-101.2%5Y-2,715.5%+2,614.3%
5Y-2,715.5%10Y-19,465.0%+16,749.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.2%-200.1%+98.9%
TTM-101.2%-216.8%+115.6%
YOY-117.5%-288.3%+170.8%
5Y-2,715.5%-449.1%-2,266.4%
10Y-19,465.0%-605.5%-18,859.5%
1.1.2. Return on Assets

Shows how efficient Genfit is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genfit to the Biotechnology industry mean.
  • -17.7% Return on Assets means that Genfit generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genfit:

  • The MRQ is -17.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.7%TTM-17.7%0.0%
TTM-17.7%YOY-11.0%-6.7%
TTM-17.7%5Y-15.4%-2.3%
5Y-15.4%10Y-19.6%+4.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.7%-13.3%-4.4%
TTM-17.7%-12.8%-4.9%
YOY-11.0%-11.7%+0.7%
5Y-15.4%-13.9%-1.5%
10Y-19.6%-15.7%-3.9%
1.1.3. Return on Equity

Shows how efficient Genfit is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genfit to the Biotechnology industry mean.
  • -45.3% Return on Equity means Genfit generated $-0.45 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genfit:

  • The MRQ is -45.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -45.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.3%TTM-45.3%0.0%
TTM-45.3%YOY-25.1%-20.2%
TTM-45.3%5Y-18.3%-27.0%
5Y-18.3%10Y-60.6%+42.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.3%-16.9%-28.4%
TTM-45.3%-16.1%-29.2%
YOY-25.1%-15.1%-10.0%
5Y-18.3%-19.3%+1.0%
10Y-60.6%-20.2%-40.4%

1.2. Operating Efficiency of Genfit.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genfit is operating .

  • Measures how much profit Genfit makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genfit to the Biotechnology industry mean.
  • An Operating Margin of -128.0% means the company generated $-1.28  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genfit:

  • The MRQ is -128.0%. The company is operating very inefficient. -2
  • The TTM is -128.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-128.0%TTM-128.0%0.0%
TTM-128.0%YOY-136.4%+8.4%
TTM-128.0%5Y-2,105.0%+1,977.0%
5Y-2,105.0%10Y-17,389.8%+15,284.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.0%-296.2%+168.2%
TTM-128.0%-232.5%+104.5%
YOY-136.4%-298.2%+161.8%
5Y-2,105.0%-492.1%-1,612.9%
10Y-17,389.8%-632.4%-16,757.4%
1.2.2. Operating Ratio

Measures how efficient Genfit is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.22 means that the operating costs are $2.22 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genfit:

  • The MRQ is 2.222. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.222. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.222TTM2.2220.000
TTM2.222YOY2.364-0.142
TTM2.2225Y22.150-19.929
5Y22.15010Y176.774-154.623
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2223.231-1.009
TTM2.2223.310-1.088
YOY2.3643.890-1.526
5Y22.1505.739+16.411
10Y176.7747.876+168.898

1.3. Liquidity of Genfit.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genfit is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.94 means the company has $2.94 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genfit:

  • The MRQ is 2.940. The company is able to pay all its short-term debts. +1
  • The TTM is 2.940. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.940TTM2.9400.000
TTM2.940YOY4.025-1.085
TTM2.9405Y4.772-1.833
5Y4.77210Y6.492-1.720
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9403.890-0.950
TTM2.9404.173-1.233
YOY4.0255.344-1.319
5Y4.7726.126-1.354
10Y6.4926.448+0.044
1.3.2. Quick Ratio

Measures if Genfit is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genfit to the Biotechnology industry mean.
  • A Quick Ratio of 2.87 means the company can pay off $2.87 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genfit:

  • The MRQ is 2.872. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.872. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.872TTM2.8720.000
TTM2.872YOY4.090-1.218
TTM2.8725Y4.744-1.873
5Y4.74410Y6.441-1.696
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8723.514-0.642
TTM2.8723.998-1.126
YOY4.0905.380-1.290
5Y4.7446.105-1.361
10Y6.4416.404+0.037

1.4. Solvency of Genfit.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genfit assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genfit to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.61 means that Genfit assets are financed with 60.9% credit (debt) and the remaining percentage (100% - 60.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genfit:

  • The MRQ is 0.609. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.609. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.609TTM0.6090.000
TTM0.609YOY0.561+0.048
TTM0.6095Y0.712-0.102
5Y0.71210Y0.564+0.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6090.339+0.270
TTM0.6090.336+0.273
YOY0.5610.271+0.290
5Y0.7120.366+0.346
10Y0.5640.389+0.175
1.4.2. Debt to Equity Ratio

Measures if Genfit is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genfit to the Biotechnology industry mean.
  • A Debt to Equity ratio of 155.9% means that company has $1.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genfit:

  • The MRQ is 1.559. The company is just able to pay all its debts with equity.
  • The TTM is 1.559. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.559TTM1.5590.000
TTM1.559YOY1.280+0.279
TTM1.5595Y1.378+0.181
5Y1.37810Y1.930-0.552
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5590.388+1.171
TTM1.5590.402+1.157
YOY1.2800.335+0.945
5Y1.3780.426+0.952
10Y1.9300.461+1.469

2. Market Valuation of Genfit

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genfit generates.

  • Above 15 is considered overpriced but always compare Genfit to the Biotechnology industry mean.
  • A PE ratio of -6.23 means the investor is paying $-6.23 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genfit:

  • The EOD is -5.576. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.232. Based on the earnings, the company is expensive. -2
  • The TTM is -6.232. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.576MRQ-6.232+0.656
MRQ-6.232TTM-6.2320.000
TTM-6.232YOY-8.653+2.422
TTM-6.2325Y-5.502-0.730
5Y-5.50210Y-2.751-2.751
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.576-2.264-3.312
MRQ-6.232-2.629-3.603
TTM-6.232-2.680-3.552
YOY-8.653-4.145-4.508
5Y-5.502-6.257+0.755
10Y-2.751-6.254+3.503
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genfit:

  • The EOD is -2.939. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.285. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.285. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.939MRQ-3.285+0.346
MRQ-3.285TTM-3.2850.000
TTM-3.285YOY-2.826-0.459
TTM-3.2855Y-4.903+1.618
5Y-4.90310Y-2.451-2.451
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.939-2.973+0.034
MRQ-3.285-3.333+0.048
TTM-3.285-3.553+0.268
YOY-2.826-5.605+2.779
5Y-4.903-8.376+3.473
10Y-2.451-8.865+6.414
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genfit is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.82 means the investor is paying $2.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genfit:

  • The EOD is 2.526. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.824. Based on the equity, the company is underpriced. +1
  • The TTM is 2.824. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.526MRQ2.824-0.297
MRQ2.824TTM2.8240.000
TTM2.824YOY2.171+0.652
TTM2.8245Y0.873+1.950
5Y0.87310Y0.437+0.437
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.5261.896+0.630
MRQ2.8242.115+0.709
TTM2.8242.093+0.731
YOY2.1712.884-0.713
5Y0.8733.542-2.669
10Y0.4373.916-3.479
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genfit.

3.1. Institutions holding Genfit

Institutions are holding 1.294% of the shares of Genfit.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30TANG CAPITAL MANAGEMENT LLC2.08820.48021040636-193800-15.6995
2023-12-31Optiver Holding B.V.0.16530.000282359788232229.1572
2023-12-31Morgan Stanley - Brokerage Accounts0.0617030763-3601-10.479
2023-12-31Millennium Management LLC0.05680.00012831017654165.6719
2023-12-31OLD MISSION CAPITAL LLC0.02490.000912428124280
2023-12-31UBS Group AG0.00230113711370
2023-12-31Rhumbline Advisers0.00140678-125-15.5666
2023-12-31Advisory Services Network, LLC0.000201001000
2023-12-31Qube Research & Technologies0.000209800
2023-12-31Susquehanna International Group, LLP000-11206-100
2023-12-31O'Shaughnessy Asset Management LLC000-13601-100
2023-09-30BNP Paribas Arbitrage, SA000-1800-100
2023-09-30Two Sigma Investments LLC000-14365-100
2023-09-30Envestnet Asset Management Inc000-41345-100
2023-09-30Advisor Group Holdings, Inc.000-18-100
Total 2.4010.48141196509-169719-14.2%

3.2. Funds holding Genfit

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28ActivePassive International Equity ETF0.0180.01148981660.7403
2024-02-29Fidelity Nasdaq Composite Index0.00650.0001321500
Total 0.02450.011512196+66+0.5%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Genfit compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.658-0.6580%-0.261-60%0.183-459%0.106-719%
Book Value Per Share--1.3641.3640%2.021-33%1.424-4%1.554-12%
Current Ratio--2.9402.9400%4.025-27%4.772-38%6.492-55%
Debt To Asset Ratio--0.6090.6090%0.561+9%0.712-14%0.564+8%
Debt To Equity Ratio--1.5591.5590%1.280+22%1.378+13%1.930-19%
Dividend Per Share----0%-0%-0%-0%
Eps---0.618-0.6180%-0.507-18%-0.679+10%-0.774+25%
Free Cash Flow Per Share---1.172-1.1720%-1.553+33%-0.793-32%-0.766-35%
Free Cash Flow To Equity Per Share---1.264-1.2640%-1.634+29%-0.397-69%0.202-725%
Gross Profit Margin--1.0001.0000%1.042-4%1.068-6%1.034-3%
Intrinsic Value_10Y_max--11.234--------
Intrinsic Value_10Y_min---9.422--------
Intrinsic Value_1Y_max--0.028--------
Intrinsic Value_1Y_min---0.839--------
Intrinsic Value_3Y_max--0.921--------
Intrinsic Value_3Y_min---2.628--------
Intrinsic Value_5Y_max--2.822--------
Intrinsic Value_5Y_min---4.518--------
Market Cap171676591.500-12%191864750.000191864750.0000%218725815.000-12%383916647.000-50%191958323.5000%
Net Profit Margin---1.012-1.0120%-1.175+16%-27.155+2585%-194.650+19143%
Operating Margin---1.280-1.2800%-1.364+7%-21.050+1545%-173.898+13489%
Operating Ratio--2.2222.2220%2.364-6%22.150-90%176.774-99%
Pb Ratio2.526-12%2.8242.8240%2.171+30%0.873+223%0.437+547%
Pe Ratio-5.576+11%-6.232-6.2320%-8.653+39%-5.502-12%-2.751-56%
Price Per Share3.445-12%3.8503.8500%4.389-12%7.588-49%3.794+1%
Price To Free Cash Flow Ratio-2.939+11%-3.285-3.2850%-2.826-14%-4.903+49%-2.451-25%
Price To Total Gains Ratio-5.238+11%-5.853-5.8530%-16.833+188%-1.656-72%-1.656-72%
Quick Ratio--2.8722.8720%4.090-30%4.744-39%6.441-55%
Return On Assets---0.177-0.1770%-0.110-38%-0.154-13%-0.196+11%
Return On Equity---0.453-0.4530%-0.251-45%-0.183-60%-0.606+34%
Total Gains Per Share---0.658-0.6580%-0.261-60%0.183-459%0.106-719%
Usd Book Value--67951000.00067951000.0000%100729036.800-33%73589447.360-8%78759117.280-14%
Usd Book Value Change Per Share---0.658-0.6580%-0.261-60%0.183-459%0.106-719%
Usd Book Value Per Share--1.3641.3640%2.021-33%1.424-4%1.554-12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.618-0.6180%-0.507-18%-0.679+10%-0.774+25%
Usd Free Cash Flow---58409000.000-58409000.0000%-77403052.800+33%-37307561.920-36%-37068350.624-37%
Usd Free Cash Flow Per Share---1.172-1.1720%-1.553+33%-0.793-32%-0.766-35%
Usd Free Cash Flow To Equity Per Share---1.264-1.2640%-1.634+29%-0.397-69%0.202-725%
Usd Market Cap171676591.500-12%191864750.000191864750.0000%218725815.000-12%383916647.000-50%191958323.5000%
Usd Price Per Share3.445-12%3.8503.8500%4.389-12%7.588-49%3.794+1%
Usd Profit---30789446.400-30789446.4000%-25276032.000-18%-32334779.520+5%-38113688.160+24%
Usd Revenue--30438864.00030438864.0000%21519792.000+41%34191480.960-11%17374117.824+75%
Usd Total Gains Per Share---0.658-0.6580%-0.261-60%0.183-459%0.106-719%
 EOD+3 -5MRQTTM+0 -0YOY+12 -225Y+9 -2510Y+13 -21

4.2. Fundamental Score

Let's check the fundamental score of Genfit based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.576
Price to Book Ratio (EOD)Between0-12.526
Net Profit Margin (MRQ)Greater than0-1.012
Operating Margin (MRQ)Greater than0-1.280
Quick Ratio (MRQ)Greater than12.872
Current Ratio (MRQ)Greater than12.940
Debt to Asset Ratio (MRQ)Less than10.609
Debt to Equity Ratio (MRQ)Less than11.559
Return on Equity (MRQ)Greater than0.15-0.453
Return on Assets (MRQ)Greater than0.05-0.177
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Genfit based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.194
Ma 20Greater thanMa 503.581
Ma 50Greater thanMa 1003.619
Ma 100Greater thanMa 2003.648
OpenGreater thanClose3.500
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets173,872
Total Liabilities105,921
Total Stockholder Equity67,951
 As reported
Total Liabilities 105,921
Total Stockholder Equity+ 67,951
Total Assets = 173,872

Assets

Total Assets173,872
Total Current Assets113,115
Long-term Assets60,757
Total Current Assets
Cash And Cash Equivalents 77,789
Net Receivables 32,707
Inventory 4
Other Current Assets 2,615
Total Current Assets  (as reported)113,115
Total Current Assets  (calculated)113,115
+/-0
Long-term Assets
Property Plant Equipment 7,872
Long-term Assets Other 48,760
Long-term Assets  (as reported)60,757
Long-term Assets  (calculated)56,632
+/- 4,125

Liabilities & Shareholders' Equity

Total Current Liabilities38,480
Long-term Liabilities67,441
Total Stockholder Equity67,951
Total Current Liabilities
Short-term Debt 7,925
Accounts payable 18,799
Other Current Liabilities 64
Total Current Liabilities  (as reported)38,480
Total Current Liabilities  (calculated)26,788
+/- 11,692
Long-term Liabilities
Long-term Liabilities  (as reported)67,441
Long-term Liabilities  (calculated)0
+/- 67,441
Total Stockholder Equity
Common Stock12,459
Retained Earnings -390,764
Accumulated Other Comprehensive Income 996
Other Stockholders Equity 445,260
Total Stockholder Equity (as reported)67,951
Total Stockholder Equity (calculated)67,951
+/-0
Other
Cash and Short Term Investments 77,789
Current Deferred Revenue11,692
Liabilities and Stockholders Equity 173,872
Net Debt -7,611
Short Long Term Debt Total 70,178



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
30,835
46,244
40,214
45,992
38,428
31,387
29,076
23,581
29,151
86,366
69,258
166,214
293,183
229,478
309,853
198,614
281,720
215,540
173,872
173,872215,540281,720198,614309,853229,478293,183166,21469,25886,36629,15123,58129,07631,38738,42845,99240,21446,24430,835
   > Total Current Assets 
17,372
28,994
22,723
28,958
23,854
19,696
19,160
11,154
27,099
83,813
66,753
161,996
283,572
218,116
290,753
184,717
268,097
158,459
113,115
113,115158,459268,097184,717290,753218,116283,572161,99666,75383,81327,09911,15419,16019,69623,85428,95822,72328,99417,372
       Cash And Cash Equivalents 
12,498
22,373
15,828
16,871
17,434
13,942
12,805
6,304
20,922
76,005
60,111
152,277
273,820
207,240
276,748
171,029
258,756
136,001
77,789
77,789136,001258,756171,029276,748207,240273,820152,27760,11176,00520,9226,30412,80513,94217,43416,87115,82822,37312,498
       Short-term Investments 
1,682
1,502
1,549
921
0
0
14
18
0
0
22
0
0
0
0
0
0
4,550
0
04,55000000022001814009211,5491,5021,682
       Net Receivables 
973
1,377
631
801
61
95
733
3,983
4,951
6,703
5,998
8,394
7,956
8,793
12,033
11,919
7,236
15,906
32,707
32,70715,9067,23611,91912,0338,7937,9568,3945,9986,7034,9513,98373395618016311,377973
       Inventory 
28
31
31
39
208
187
173
158
167
248
28
14
4
4
4
4
4
4
4
4444444142824816715817318720839313128
       Other Current Assets 
2,152
3,672
4,640
10,325
6,152
5,473
5,435
-1
0
-1
585
1,137
1,792
1
1,968
1,765
2,101
1,998
2,615
2,6151,9982,1011,7651,96811,7921,137585-10-15,4355,4736,15210,3254,6403,6722,152
   > Long-term Assets 
13,463
17,250
17,491
17,034
14,574
11,691
9,916
12,428
2,052
2,553
2,505
4,219
9,611
11,362
19,099
13,897
13,623
57,081
60,757
60,75757,08113,62313,89719,09911,3629,6114,2192,5052,5532,05212,4289,91611,69114,57417,03417,49117,25013,463
       Property Plant Equipment 
10,017
9,897
9,382
9,576
9,160
8,375
7,641
9,401
1,000
1,333
1,324
3,010
6,324
7,764
16,453
11,648
9,015
8,210
7,872
7,8728,2109,01511,64816,4537,7646,3243,0101,3241,3331,0009,4017,6418,3759,1609,5769,3829,89710,017
       Goodwill 
0
0
75
0
0
75
0
75
75
75
0
0
0
0
0
0
0
0
0
000000000757575075007500
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
109
267
770
1,023
1,458
4,431
4,914
0
04,9144,4311,4581,02377026710900000000000
       Intangible Assets 
221
344
241
0
0
105
75
31
56
86
562
667
636
795
920
791
174
43,957
0
043,9571747919207956366675628656317510500241344221
       Long-term Assets Other 
3,224
6,087
4,320
3,925
1,775
1,066
2,008
0
0
299
7
433
1
1
-1
1,726
3
4,434
48,760
48,7604,43431,726-1114337299002,0081,0661,7753,9254,3206,0873,224
> Total Liabilities 
17,448
18,473
14,846
23,610
22,908
22,998
24,619
16,747
15,058
15,937
13,842
23,417
188,954
208,539
225,788
214,776
162,623
121,012
105,921
105,921121,012162,623214,776225,788208,539188,95423,41713,84215,93715,05816,74724,61922,99822,90823,61014,84618,47317,448
   > Total Current Liabilities 
7,496
9,407
7,430
14,112
9,555
11,806
0
8,495
9,075
10,391
8,613
17,562
27,106
39,248
43,495
31,067
62,837
39,370
38,480
38,48039,37062,83731,06743,49539,24827,10617,5628,61310,3919,0758,495011,8069,55514,1127,4309,4077,496
       Short-term Debt 
1,113
792
717
6,822
2,908
0
0
3,113
1,821
1,666
1,223
1,249
3,163
3,154
4,377
4,348
2,188
5,080
7,925
7,9255,0802,1884,3484,3773,1543,1631,2491,2231,6661,8213,113002,9086,8227177921,113
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
1,199
1,170
2,743
2,634
2,425
4,348
2,188
5,080
0
05,0802,1884,3482,4252,6342,7431,1701,1990000000000
       Accounts payable 
3,380
4,687
3,589
3,549
3,706
4,143
0
2,926
5,454
5,900
5,275
13,341
19,053
32,649
36,917
25,564
40,988
14,845
18,799
18,79914,84540,98825,56436,91732,64919,05313,3415,2755,9005,4542,92604,1433,7063,5493,5894,6873,380
       Other Current Liabilities 
2,585
3,636
2,727
3,708
2,783
7,663
0
1,544
1,630
2,565
2,086
2,971
4,889
3,444
2,062
1,031
5,363
4,966
64
644,9665,3631,0312,0623,4444,8892,9712,0862,5651,6301,54407,6632,7833,7082,7273,6362,585
   > Long-term Liabilities 
7,636
5,564
4,559
9,499
13,353
11,192
0
8,252
5,983
5,546
5,229
5,855
161,848
169,291
182,293
183,709
99,786
81,642
67,441
67,44181,64299,786183,709182,293169,291161,8485,8555,2295,5465,9838,252011,19213,3539,4994,5595,5647,636
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
747
851
3,103
2,860
3,050
2,366
27,739
0
0
0027,7392,3663,0502,8603,1038517470000000000
> Total Stockholder Equity
13,343
27,771
25,368
22,382
15,520
8,389
4,457
6,834
14,093
70,429
55,416
142,797
104,229
20,939
84,065
-16,162
119,097
94,528
67,951
67,95194,528119,097-16,16284,06520,939104,229142,79755,41670,42914,0936,8344,4578,38915,52022,38225,36827,77113,343
   Common Stock
2,400
2,818
2,818
2,818
2,818
2,916
3,408
4,011
5,135
5,989
5,990
7,792
7,792
7,796
9,715
9,722
12,454
12,459
12,459
12,45912,45912,4549,7229,7157,7967,7927,7925,9905,9895,1354,0113,4082,9162,8182,8182,8182,8182,400
   Retained Earnings 
1,773
328
-2,801
-3,961
-7,374
-9,381
-20,367
-5,412
-35,668
-17,025
-68,627
-102,321
-161,135
-238,418
-303,484
-404,850
-337,817
-361,269
-390,764
-390,764-361,269-337,817-404,850-303,484-238,418-161,135-102,321-68,627-17,025-35,668-5,412-20,367-9,381-7,374-3,961-2,8013281,773
   Accumulated Other Comprehensive Income 
8,561
10,264
10,990
-6,401
-7,316
-7,943
-32
-17,284
311
-34,379
15
21
-8
6
14
-92
22
-1,344
996
996-1,34422-92146-82115-34,379311-17,284-32-7,943-7,316-6,40110,99010,2648,561
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
610
14,362
14,362
29,926
27,392
22,797
21,449
25,519
44,315
115,844
118,038
237,305
257,580
251,555
377,820
379,058
444,438
444,682
445,260
445,260444,682444,438379,058377,820251,555257,580237,305118,038115,84444,31525,51921,44922,79727,39229,92614,36214,362610



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue28,565
Cost of Revenue--
Gross Profit28,56528,565
 
Operating Income (+$)
Gross Profit28,565
Operating Expense-63,466
Operating Income-36,555-34,901
 
Operating Expense (+$)
Research Development46,503
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense63,46646,503
 
Net Interest Income (+$)
Interest Income-
Interest Expense-5,614
Other Finance Cost-5,614
Net Interest Income-
 
Pretax Income (+$)
Operating Income-36,555
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-28,514-44,596
EBIT - interestExpense = -42,169
-28,514
-23,280
Interest Expense5,614
Earnings Before Interest and Taxes (EBIT)-36,555-22,900
Earnings Before Interest and Taxes (EBITDA)-34,901
 
After tax Income (+$)
Income Before Tax-28,514
Tax Provision--
Net Income From Continuing Ops--28,514
Net Income-28,894
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses65,120
Total Other Income/Expenses Net8,0410
 

Technical Analysis of Genfit
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genfit. The general trend of Genfit is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genfit's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genfit.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.8 < 4.04 < 4.04.

The bearish price targets are: 3.41 > 3.3959 > 3.31.

Tweet this
Genfit Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genfit. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genfit Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genfit. The current macd is -0.02056077.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genfit price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genfit. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genfit price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genfit Daily Moving Average Convergence/Divergence (MACD) ChartGenfit Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genfit. The current adx is 10.31.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genfit shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Genfit Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genfit. The current sar is 3.71324051.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Genfit Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genfit. The current rsi is 44.19. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Genfit Daily Relative Strength Index (RSI) ChartGenfit Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genfit. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genfit price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genfit Daily Stochastic Oscillator ChartGenfit Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genfit. The current cci is -149.30350938.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Genfit Daily Commodity Channel Index (CCI) ChartGenfit Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genfit. The current cmo is -14.87128284.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Genfit Daily Chande Momentum Oscillator (CMO) ChartGenfit Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genfit. The current willr is -88.775.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Genfit Daily Williams %R ChartGenfit Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genfit.

Genfit Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genfit. The current atr is 0.18230057.

Genfit Daily Average True Range (ATR) ChartGenfit Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genfit. The current obv is -2,330,427.

Genfit Daily On-Balance Volume (OBV) ChartGenfit Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genfit. The current mfi is 59.76.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Genfit Daily Money Flow Index (MFI) ChartGenfit Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genfit.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Genfit Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genfit based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.194
Ma 20Greater thanMa 503.581
Ma 50Greater thanMa 1003.619
Ma 100Greater thanMa 2003.648
OpenGreater thanClose3.500
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genfit with someone you think should read this too:
  • Are you bullish or bearish on Genfit? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genfit? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genfit

I send you an email if I find something interesting about Genfit.


Comments

How you think about this?

Leave a comment

Stay informed about Genfit.

Receive notifications about Genfit in your mailbox!